Transaction #18729 · Form 4 · 0001782135-25-000015
GILEAD SCIENCES, INC. · Exercise / conversion · Common Stock
GILEAD SCIENCES, INC. · Transacted December 10, 2025 · Filed December 11, 2025
What does this filing report?
An SEC Form 4 filing for GILEAD SCIENCES, INC. records an exercise / conversion involving Common Stock on December 10, 2025. The reported quantity was 3,842. The filing date is December 11, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- GILEAD SCIENCES, INC.
- Company CIK
- 0000882095
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 3,842
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 111,035
- Ownership description
- Not reported
- SEC acceptance time
- Dec 11, 2025, 6:25 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Mercier Johanna ↗
Chief Commercial Officer
CIK 0001782135
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2
- The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.